Search

Author/Creator Vyas, Purvi

1. Discovery of 1, 3-dihydro-2H-imidazo[4, 5-c]quinolin-2-ones based novel, potent and PI3Kδ selective inhibitors. Issue 11 (1st June 2019)

Authors:
Bahekar, Rajesh; Dave, Bhushan; Soman, Shubhangi; Patel, Dipam; Chopade, Rajendra; Funde, Radhika; Kumar, Jeevan; Sachchidanand, S.; Giri, Poonam; Chatterjee, Abhijit; Mahapatra, Jogeswar; Vyas, Purvi; Ghoshdastidar, Krishnarup; Bandyopadhyay, Debdutta; Desai, Ranjit C.
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 29:Issue 11(2019)
Page Start:
1313
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid‐lowering and insulin‐sensitizing effects in preclinical models. Issue 3 (4th May 2015)

Authors:
Jain, Mukul R.; Giri, Suresh R.; Trivedi, Chitrang; Bhoi, Bibhuti; Rath, Akshyaya; Vanage, Geeta; Vyas, Purvi; Ranvir, Ramchandra; Patel, Pankaj R.
Journal:
Pharmacology research & perspectives
Issue:
Volume 3:Issue 3(2015:Jun.)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗